Page results
-
The Edward Showler Foundation and UCL have forged a philanthropic partnership that will support pioneering research into clear cell sarcoma (CCS) – a rare type of soft tissue cancer with few…
-
The Royal Parks Half Marathon makes a spectacular return this weekend.
-
It is with great pleasure and excitement that we share with you news of an excellent new resource that can be used across the UK for people living with Sickle Cell Disorder.
-
A UCLH investment of £20 million will fund training for healthcare assistants and major new research facilities which will benefit patient care.
-
A new diagnostic pathway has been developed for adult soft tissue sarcoma referrals in London, using a Hub and Spoke service model. Wood Green CDC is now an additional diagnostic site…
-
A clinical trial at UCLH will investigate whether a new type of immune therapy can prevent colorectal cancer from returning.
-
The first UK participant in a portion of a study looking at a new investigational medication for Covid-19 has received their initial dose of the drug at UCLH.
-
People with the acquired communication disorder aphasia – which involves problems with the understanding or production of speech –have benefitted greatly from a two-year programme of therapy at the National Hospital for Neurology and Neurosurgery at UCLH.
